AAAAAA
Results:
1-24
|
Results: 24
Authors:
UCKUN FM
NARLA RK
ZEREN T
YANISHEVSKI Y
MYERS DE
WAURZYNIAK B
EK O
SCHNEIDER E
MESSINGER Y
CHELSTROM LM
GUNTHER R
EVANS W
Citation: Fm. Uckun et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTICANCER ACTIVITY OF GENISTEIN LINKED TO RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR, Clinical cancer research, 4(5), 1998, pp. 1125-1134
Authors:
UCKUN FM
NARLA RK
ZEREN T
YANISHEVSKI Y
MYERS DE
WAURZYNIAK B
EK O
SCHNEIDER E
MESSINGER Y
CHELSTROM LM
GUNTHER R
EVANS W
Citation: Fm. Uckun et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTICANCER ACTIVITY OF GENISTEIN LINKED TO RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR, Clinical cancer research, 4(5), 1998, pp. 1125-1134
Authors:
EK O
GAYNON P
ZEREN T
CHELSTROM LM
MYERS DE
UCKUN FM
Citation: O. Ek et al., TREATMENT OF HUMAN B-CELL PRECURSOR LEUKEMIA IN SCID MICE BY USING A COMBINATION OF THE ANTI-CD19 IMMUNOTOXIN B43-PAP WITH THE STANDARD CHEMOTHERAPEUTIC DRUGS VINCRISTINE, METHYLPREDNISOLONE, AND L-ASPARAGINASE, Leukemia & lymphoma, 31(1-2), 1998, pp. 143-149
Authors:
EK O
REAMAN GH
CRANKSHAW DL
CHELSTROM LM
MYERS DE
UCKUN FM
Citation: O. Ek et al., COMBINED THERAPEUTIC EFFICACY OF THE THYMIDYLATE SYNTHASE INHIBITOR ZD1694 (TOMUDEX) AND THE IMMUNOTOXIN B43(ANTI-CD19)-PAP IN A SCID MOUSEMODEL OF HUMAN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 28(5-6), 1998, pp. 509-514
Authors:
UCKUN FM
CHELSTROM LM
TUELAHLGREN L
DIBIRDIK I
IRVIN JD
LANGLIE EC
MYERS DE
Citation: Fm. Uckun et al., TXU (ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN AS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 383-388
Authors:
WAURZYNIAK B
SCHNEIDER EA
TUMER N
YANISHEVSKI Y
GUNTHER R
CHELSTROM LM
WENDORF H
MYERS DE
IRVIN JD
MESSINGER Y
EK O
ZEREN T
LANGLIE MC
EVANS WE
UCKUN FM
Citation: B. Waurzyniak et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTILEUKEMIC ACTIVITY OF TXU (ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN, Clinical cancer research, 3(6), 1997, pp. 881-890
Authors:
UCKUN FM
YANISHEVSKI Y
TUMER N
WAURZYNIAK B
MESSINGER Y
CHELSTROM LM
LISOWSKI EA
EK O
ZEREN T
WENDORF H
LANGLIE MC
IRVIN JD
MYERS DE
FULLER GB
EVANS W
GUNTHER R
Citation: Fm. Uckun et al., PHARMACOKINETIC FEATURES, IMMUNOGENICITY, AND TOXICITY OF B43(ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN IN CYNOMOLGUS MONKEYS, Clinical cancer research, 3(3), 1997, pp. 325-337
Authors:
PERENTESIS JP
GUNTHER R
WAURZYNIAK B
YANISHEVSKI Y
MYERS DE
EK O
MESSINGER Y
SHAO Y
CHELSTROM LM
SCHNEIDER E
EVANS WE
UCKUN FM
Citation: Jp. Perentesis et al., IN-VIVO BIOTHERAPY OF HL-60 MYELOID-LEUKEMIA WITH A GENETICALLY-ENGINEERED RECOMBINANT FUSION TOXIN DIRECTED AGAINST THE HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR, Clinical cancer research, 3(12), 1997, pp. 2217-2227
Authors:
MESSINGER Y
YANISHEVSKI Y
AVRAMIS VI
EK O
CHELSTROM LM
GUNTHER R
MYERS DE
IRVIN JD
EVANS W
UCKUN FM
Citation: Y. Messinger et al., TREATMENT OF HUMAN B-CELL PRECURSOR LEUKEMIA IN SCID MICE USING A COMBINATION OF THE INVESTIGATIONAL BIOTHERAPEUTIC AGENT B43-PAP WITH CYTOSINE-ARABINOSIDE, Clinical cancer research, 2(9), 1996, pp. 1533-1542
Authors:
MYERS DE
CHANDANLANGLIE M
CHELSTROM LM
UCKUN FM
Citation: De. Myers et al., IN-VITRO AND IN-VIVO ANTILEUKEMIC EFFICACY OF CYCLIC-AMP MODULATING AGENTS AGAINST HUMAN LEUKEMIC B-CELL PRECURSORS, Leukemia & lymphoma, 22(3-4), 1996, pp. 259-264
Authors:
GUNTHER R
CHELSTROM LM
WENDORF HR
SCHNEIDER EA
COVALCIUC K
JOHNSON B
CLEMENTSON D
IRVIN JD
MYERS DE
UCKUN FM
Citation: R. Gunther et al., TOXICITY PROFILE OF THE INVESTIGATIONAL NEW BIOTHERAPEUTIC AGENT, B43(ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN, Leukemia & lymphoma, 22(1-2), 1996, pp. 61
Authors:
MYERS DE
JUN X
WADDICK KG
FORSYTH C
CHELSTROM LM
GUNTHER RL
TUMER NE
BOLEN J
UCKUN FM
Citation: De. Myers et al., MEMBRANE-ASSOCIATED CD19-LYN COMPLEX IS AN ENDOGENOUS P53-INDEPENDENTAND BCL-2-INDEPENDENT REGULATOR OF APOPTOSIS IN HUMAN B-LINEAGE LYMPHOMA-CELLS (VOL 92, PG 9575, 1995), Proceedings of the National Academy of Sciences of the United Statesof America, 93(3), 1996, pp. 1357-1357
Authors:
PERENTESIS JP
GUNTHER R
WAURZYNIAK B
CHELSTROM LM
BENDEL AE
DAVIES SM
SHAO Y
WARMAN B
CHANDANLANGLIE M
WADDICK KG
YANISHEVSKI Y
EVANS WE
UCKUN FM
Citation: Jp. Perentesis et al., IN-VIVO ANTIMYELOID LEUKEMIA ACTIVITY OF A RECOMBINANT FUSION TOXIN TARGETED TO THE HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR, Blood, 88(10), 1996, pp. 831-831
Authors:
WADDICK KG
FINNEGAN DM
CHELSTROM LM
UCKUN FM
Citation: Kg. Waddick et al., IN-VIVO RADIOSENSITIZING EFFECTS OF RECOMBINANT INTERLEUKIN-6 ON RADIATION-RESISTANT BCL-1 B-LINEAGE LEUKEMIA-CELLS IN A MURINE SYNGENEIC BONE-MARROW TRANSPLANT MODEL SYSTEM, Leukemia & lymphoma, 19(1-2), 1995, pp. 121-128
Authors:
UCKUN FM
EVANS WE
FORSYTH CJ
WADDICK KG
AHLGREN LT
CHELSTROM LM
BURKHARDT A
BOLEN J
MYERS DE
Citation: Fm. Uckun et al., BIOTHERAPY OF B-CELL PRECURSOR LEUKEMIA BY TARGETING GENISTEIN TO CD19-ASSOCIATED TYROSINE KINASES, Science, 267(5199), 1995, pp. 886-891
Authors:
MYERS DE
JUN X
WADDICK KG
FORSYTH C
CHELSTROM LM
GUNTHER RL
TUMER NE
BOLEN J
UCKUN FM
Citation: De. Myers et al., MEMBRANE-ASSOCIATED CD19-LYN COMPLEX IS AN ENDOGENOUS P53-INDEPENDENTAND BCL-2-INDEPENDENT REGULATOR OF APOPTOSIS IN HUMAN B-LINEAGE LYMPHOMA-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(21), 1995, pp. 9575-9579
Authors:
WADDICK KG
MYERS DE
GUNTHER R
CHELSTROM LM
CHANDANLANGLIE M
IRVIN JD
TUMER N
UCKUN FM
Citation: Kg. Waddick et al., IN-VITRO AND IN-VIVO ANTILEUKEMIC ACTIVITY OF B43-POKEWEED ANTIVIRAL PROTEIN AGAINST RADIATION-RESISTANT HUMAN B-CELL PRECURSOR LEUKEMIA-CELLS, Blood, 86(11), 1995, pp. 4228-4233
Authors:
GUNTHER R
CHELSTROM LM
TUELAHLGREN L
SIMON J
MYERS DE
UCKUN FM
Citation: R. Gunther et al., BIOTHERAPY FOR XENOGRAFTED HUMAN CENTRAL-NERVOUS-SYSTEM LEUKEMIA IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY USING B43 (ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN, Blood, 85(9), 1995, pp. 2537-2545
Authors:
UCKUN FM
STEWART CF
REAMAN G
CHELSTROM LM
JIN JH
CHANDANLANGLIE M
WADDICK KG
WHITE J
EVANS WE
Citation: Fm. Uckun et al., IN-VITRO AND IN-VIVO ACTIVITY OF TOPOTECAN AGAINST HUMAN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS, Blood, 85(10), 1995, pp. 2817-2828
Authors:
UCKUN FM
DOWNING JR
CHELSTROM LM
GUNTHER R
RYAN M
SIMON J
CARROLL AJ
TUELAHLGREN L
CRIST WM
Citation: Fm. Uckun et al., HUMAN T(411)(Q21Q23) ACUTE LYMPHOBLASTIC-LEUKEMIA IN MICE WITH SEVERECOMBINED IMMUNODEFICIENCY, Blood, 84(3), 1994, pp. 859-865
Authors:
WADDICK KG
MYERS DE
CHELSTROM LM
FINNEGAN D
UCKUN FM
Citation: Kg. Waddick et al., RADIOIMMUNOTHERAPY CONFERS EXTENDED SURVIVAL TO SCID MICE CHALLENGED WITH THERAPY-REFRACTORY HUMAN PRE-B ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 84(10), 1994, pp. 10000498-10000498
Authors:
CHELSTROM LM
GUNTHER R
SIMON J
RAIMONDI SC
KRANCE R
CRIST WM
UCKUN FM
Citation: Lm. Chelstrom et al., CHILDHOOD ACUTE MYELOID-LEUKEMIA IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY, Blood, 84(1), 1994, pp. 20-26
Authors:
UCKUN FM
MYERS DE
IRVIN JD
KUEBELBECK VM
FINNEGAN D
CHELSTROM LM
HOUSTON LL
Citation: Fm. Uckun et al., EFFECTS OF THE INTERMOLECULAR TOXIN-MONOCLONAL ANTIBODY LINKAGE ON THE INVIVO STABILITY, IMMUNOGENICITY AND ANTILEUKEMIC ACTIVITY OF B43 (ANTI-CD19) POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN, Leukemia & lymphoma, 9(6), 1993, pp. 459-476
Authors:
UCKUN FM
DOWNING JR
GUNTHER R
CHELSTROM LM
FINNEGAN D
LAND VJ
BOROWITZ MJ
CARROLL AJ
CRIST WM
Citation: Fm. Uckun et al., HUMAN T(1-19)(Q23-P13) PRE-B ACUTE LYMPHOBLASTIC-LEUKEMIA IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY, Blood, 81(11), 1993, pp. 3052-3062
Risultati:
1-24
|